Literature DB >> 32185968

Jinghua Weikang capsule protects against Helicobacter pylori-induced inflammatory responses via the nuclear factor-kappa B signaling pathway.

Zongming Shi1, Hui Ye1, Jing Yu1, Xuezhi Zhang1, Hong Cheng2, Jiang Li2.   

Abstract

OBJECTIVE: To investigate the inhibitory effect of Jinghua Weikang capsule (JWC) on gastric inflammation induced by Helicobacter pylori (H. pylori) via the nuclear factor-kappa B (NF-¦ÊB) signaling pathway in Kunming mice.
METHODS: We investigated the anti-inflammation potential of JWC extract in vivo in a H. pylori-induced gastritis mouse model. The expression of inflammation-related molecules was evaluated by Western blotting, and the concentrations of in vivo inflammatory markers were measured by enzyme-linked immunosorbent assay. Inflammatory cell infiltration was evaluated by histopathological examination, and mRNA levels of related genes were evaluated by quantitative reverse transcription polymerase chain reaction.
RESULTS: JWC had a dose-dependent protective effect against H. pylori-induced gastritis by protecting gastric epithelial cells and inhibiting inflammatory cell infiltration. Mechanistically, JWC decreased the protein levels of phosphorylated I¦ÊB¦Á and NF-¦ÊB p65, mRNA levels of NF-¦ÊB pathway molecules, and plasma levels of tumor necrosis factor-¦Á and interleukin 1 beta.
CONCLUSION: An important finding of our study is that JWC attenuated gastrointestinal inflammation and ulceration and exerted a protective effect against gastric injury via inhibition of inflammation reactions and regulating the canonical NF-κB signaling pathway in vivo.

Entities:  

Keywords:  Helicobacter pylori; Jinghua Weikang capsule; NF-kappa B; Signal transduction

Year:  2018        PMID: 32185968

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  2 in total

1.  Jinghua Weikang capsule for helicobacter pylori eradication: A systematic review and meta-analysis with trial sequential analysis.

Authors:  Qian Zhao; Wen-Jia Wang; Shui-Ping Zhou; Jing Su; He Sun; Jing-Bo Zhai; Yun-Hui Hu
Journal:  Front Pharmacol       Date:  2022-09-26       Impact factor: 5.988

Review 2.  Efficacy of complementary medicine for nonsteroidal anti-inflammatory drug-induced small intestinal injuries: A narrative review.

Authors:  Minji Cho; Youngmin Bu; Jae-Woo Park; Hasanur Rahman; Seok-Jae Ko
Journal:  Medicine (Baltimore)       Date:  2021-12-03       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.